Abstracts

Intrahepatic cccDNA and Circulating HBV Markers in HBeAg-Negative Chronic Infection in Senegal

Background: A better understanding of the relationship between the intrahepatic hepatitis B virus (HBV) activity and peripheral biomarkers of HBV infection is urgently needed in order to improve treatment monitoring and outcomes in high prevalence settings. We aimed to determine the relationship between intrahepatic HBV cccDNA and plasma HBV DNA, quantitative HBsAg (qHBsAg) and total…

Saliva Kaposi Sarcoma Herpesvirus Levels as a Diagnostic Marker of Visceral Kaposi Sarcoma

Background: Kaposi sarcoma (KS), an HIV-associated malignancy, is caused by Kaposi sarcoma herpesvirus (KSHV). KS commonly affects the skin but can also lead to symptomatic visceral manifestations in the pulmonary and gastrointestinal (GI) tracts; it requires invasive procedures such as bronchoscopy or endoscopy for diagnosis. We assessed the outcomes of patients (pts) with visceral KS…

Circulating HBsAg-Specific B-Cells Are Partially Rescued After Achieving Functional Cure

Background: Hepatitis B surface antigen (HBsAg) loss defines a functional cure for chronic hepatitis B infection. Herein, we aimed to characterize circulating HBsAg-specific B cells and identify B-cell epitopes directly associated with HBsAg loss. Methods: Seventy-eight treatment-naïve patients with chronic HBV infection were classified into 4 groups according to the EASL guidelines (2017): hepatitis B…

Prevalence and Incidence of Hepatitis B Among People Living With HIV in 4 Sub-Saharan Countries

Background: Chronic hepatitis B is increasing despite it being a vaccine-preventable disease. Africa remains among the regions with the highest number of hepatitis B surface antigen (HBsAg) positive individuals with many studies suggesting HBV transmission occurring predominantly in childhood. To better understand the burden of hepatitis B infection in Sub-Saharan Africa, we assessed the prevalence…

Epidemiologic Burden of Hepatitis D Virus in the United States

Background: Hepatitis D affects nearly 5% of people globally who have a chronic infection with hepatitis B, according to the World Health Organization. The prevalence of hepatitis D virus (HDV) in the United States is generally considered lower than in other countries; however, HDV seroprevalence studies of the US population are limited, and reported ranges…

Navigation is Superior to Clinician Referral for Linkage to HCV Care from the Emergency Department

Background: Emergency departments (EDs) serve as important clinical settings for hepatitis C (HCV) screening and care, yet optimal methods of linkage-to-care for HCV-diagnosed individuals remain unknown. The goal of this study was to test the effectiveness of linkage navigation (LN) and clinician referral (CR) among ED patients identified with untreated HCV with a primary hypothesis…

High Completion and Cure Rates With a Decentralized, Integrated HCV Treatment Approach in Vietnam

Background: WHO recommends a simplified service delivery approach to the treatment of chronic hepatitis C (HCV) infection including decentralization to the primary care level and integration into existing services. In 2021, with support from the Global Fund, the Vietnam Administration for HIV/AIDS Control within the Ministry of Health scaled up HCV treatment at public HIV…

Elimination of HCV Among People With HIV in Australia

Background: An estimated 2000-2500 people were living with HIV/HCV coinfection in Australia prior to availability of HCV direct-acting antivirals (DAAs). Rapid DAA scale-up occurred from 2016 following unrestricted DAA access for adults. The aim of this analysis was to evaluate progress towards HCV elimination among people with HIV in Australia. Methods: The CEASE prospective cohort…